Trials / Completed
CompletedNCT03647982
Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers
Open-Label, Active Controlled, Single-Center, Phase 1 Study to Determine the Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Medy-Tox · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To determine the anhidrotic area and safety of MEDITOXIN
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Meditoxin | injection of MEDITOXIN into the intradermal of each contralateral upper back in equal doses |
| DRUG | Botox | injection of Botox into the intradermal of each contralateral upper back in equal doses |
Timeline
- Start date
- 2018-03-20
- Primary completion
- 2018-10-20
- Completion
- 2018-11-20
- First posted
- 2018-08-27
- Last updated
- 2019-03-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03647982. Inclusion in this directory is not an endorsement.